Cargando…

P53 and Beta-Catenin Activity during Estrogen treatment of Osteoblasts

BACKGROUND: This study was undertaken to examine the relationship between the tumor suppressor gene p53 and the nuclear signaling protein beta-catenin during bone differentiation. Cross talk between p53 and beta-catenin pathways has been demonstrated and is important during tumorigenesis and DNA dam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandar, Nalini, Saluja, Rasleen, Lamar, Peter C, Kolman, Kevin, Prozialeck, Walter C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1192811/ https://www.ncbi.nlm.nih.gov/pubmed/16053526 http://dx.doi.org/10.1186/1475-2867-5-24

Ejemplares similares

Differential expression of E-cadherin, N-cadherin and beta-catenin in proximal and distal segments of the rat nephron.
por: Prozialeck, Walter C, et al.
Publicado: (2004)

P53 regulation of osteoblast differentiation is mediated through specific microRNAs
por: Shah, Shivang, et al.
Publicado: (2021)

Activation of p53, inhibition of telomerase activity and induction of estrogen receptor beta are associated with the anti-growth effects of combination of ovarian hormones and retinoids in immortalized human mammary epithelial cells
por: Zhang, Jiahui, et al.
Publicado: (2005)

EFTUD2 gene deficiency disrupts osteoblast maturation and inhibits chondrocyte differentiation via activation of the p53 signaling pathway
por: Wu, Jing, et al.
Publicado: (2019)

Effects of sub-chronic Cd exposure on levels of copper, selenium, zinc, iron and other essential metals in rat renal cortex
por: Prozialeck, Walter C., et al.
Publicado: (2016)

Expression pattern of the apoptosis-stimulating protein of p53 family in p53(+) human breast cancer cell lines
por: Wang, Changsong, et al.
Publicado: (2013)

Apoptosis and p53 expression in rat adjuvant arthritis
por: Tak, Paul P, et al.
Publicado: (2000)

Eurycomanone induce apoptosis in HepG2 cells via up-regulation of p53
por: Zakaria, Yusmazura, et al.
Publicado: (2009)

P53 autoantibodies in 1006 patients followed up for breast cancer
por: Metcalfe, Su, et al.
Publicado: (2000)

TRIM3 inhibits P53 signaling in breast cancer cells
por: Wang, Xinxing, et al.
Publicado: (2020)

Establishment of a doxycycline-regulated cell line with inducible, doubly-stable expression of the wild-type p53 gene from p53-deleted hepatocellular carcinoma cells
por: Chi, Tian-Yi, et al.
Publicado: (2005)

Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma
por: Fu, Rong, et al.
Publicado: (2014)

ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors
por: Fitzgerald, Lily M., et al.
Publicado: (2016)

Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles
por: Antoun, Stephanie, et al.
Publicado: (2018)

Etoposide induces cell death via mitochondrial-dependent actions of p53
por: Jamil, Sarwat, et al.
Publicado: (2015)

Gene Expression Profiles Resulting from Stable Loss of p53 Mirrors Its Role in Tissue Differentiation
por: Couture, Oliver, et al.
Publicado: (2013)

Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells
por: Saini, Heena, et al.
Publicado: (2021)

Estrogen mediated expression of nucleophosmin 1 in human endometrial carcinoma clinical stages through estrogen receptor-α signaling
por: Zhou, Yunxiao, et al.
Publicado: (2014)

Synergistic anticancer effect of combined crocetin and cisplatin on KYSE-150 cells via p53/p21 pathway
por: Li, Sheng, et al.
Publicado: (2017)

Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone disease
por: Fu, Rong, et al.
Publicado: (2014)

Transactivation of the estrogen receptor promoter by BRCA1
por: Archey, William B., et al.
Publicado: (2017)

Altered expression of estrogen receptor-α variant messenger RNAs between adjacent normal breast and breast tumor tissues
por: Leygue, Etienne, et al.
Publicado: (2000)

p33ING1b regulates acetylation of p53 in oral squamous cell carcinoma via SIR2
por: Li, Xiao-han, et al.
Publicado: (2020)

Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis
por: Bado, Igor, et al.
Publicado: (2017)

A Method for the Evaluation of Site-Specific Nephrotoxic Injury in the Intact Rat Kidney
por: Edwards, Joshua, et al.
Publicado: (2020)

Lack of p53 function promotes radiation-induced mitotic catastrophe in mouse embryonic fibroblast cells
por: Ianzini, Fiorenza, et al.
Publicado: (2006)

Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways
por: Zamanian, Mohammadreza, et al.
Publicado: (2016)

TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination
por: Chen, Jia-xin, et al.
Publicado: (2021)

STAT1 inhibits human hepatocellular carcinoma cell growth through induction of p53 and Fbxw7
por: Chen, Jiayu, et al.
Publicado: (2015)

Molecular mechanism leading to SAHA-induced autophagy in tumor cells: evidence for a p53-dependent pathway
por: Fröhlich, Leopold F., et al.
Publicado: (2016)

Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis
por: Maaroufi, Younes, et al.
Publicado: (2000)

A novel method for the evaluation of proximal tubule epithelial cellular necrosis in the intact rat kidney using ethidium homodimer
por: Edwards, Joshua R, et al.
Publicado: (2007)

Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States
por: Prozialeck, Walter C., et al.
Publicado: (2021)

RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway
por: Shi, Rui, et al.
Publicado: (2022)

p53 and Beta-Catenin Expression in Gallbladder Tissues and Correlation with Tumor Progression in Gallbladder Cancer
por: Ghosh, Mila, et al.
Publicado: (2013)

Immunohistochemical analysis of beta-catenin, E-cadherin and p53 in canine gastrointestinal epithelial tumors
por: SAITO, Tsubasa, et al.
Publicado: (2020)

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
por: Turk, Casey M, et al.
Publicado: (2012)

SNHG29 regulates miR-223-3p/CTNND1 axis to promote glioblastoma progression via Wnt/β-catenin signaling pathway
por: Han, Lizhang, et al.
Publicado: (2019)

miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling
por: Han, Hu, et al.
Publicado: (2022)

Biological indicators of chemoresistance: an ex vivo analysis of γH2AX and p53 expression in feline injection-site sarcomas
por: Bing, Yike, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eidnp3a1quincahatt3h67frmd